持续的降阶梯趋势：对于颈部疾病有限的乳头状甲状腺癌，辅助性放射性碘治疗真的有必要吗？ - Suppr

Suppr

超能文献

Continuing De-escalation Trends: Is Adjuvant Radioactive Iodine Administration Truly Needed for Papillary Thyroid Carcinoma with Limited Cervical Disease?

作者信息

Goldfarb Melanie, Ullman Nicholas

机构信息

Providence Saint John's Cancer Institute (formerly the John Wayne), Santa Monica, California, USA.

出版信息

Ann Surg Oncol. 2025 Mar;32(3):1406-1407. doi: 10.1245/s10434-024-16590-1. Epub 2024 Dec 12.

DOI:10.1245/s10434-024-16590-1

PMID:39666191

Abstract

摘要

相似文献

Continuing De-escalation Trends: Is Adjuvant Radioactive Iodine Administration Truly Needed for Papillary Thyroid Carcinoma with Limited Cervical Disease?持续的降阶梯趋势：对于颈部疾病有限的乳头状甲状腺癌，辅助性放射性碘治疗真的有必要吗？

Ann Surg Oncol. 2025 Mar;32(3):1406-1407. doi: 10.1245/s10434-024-16590-1. Epub 2024 Dec 12.

Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.放射性碘治疗与经典的甲状腺乳头状癌（直径大于 4 厘米且局限于甲状腺内）患者的疾病特异性生存改善无关。

Surgery. 2024 Jan;175(1):215-220. doi: 10.1016/j.surg.2023.04.065. Epub 2023 Oct 26.

Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.放射性碘对 2 厘米以下侵袭性甲状腺乳头状癌变异型患者的总生存率无改善。

Surgery. 2022 Jan;171(1):203-211. doi: 10.1016/j.surg.2021.05.054. Epub 2021 Aug 10.

Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case report.气管结节及气管旁软组织结节：放射性碘治疗后转移性滤泡状变异型甲状腺乳头状癌的特殊影像学及病理表现改变：一例病例报告

J Med Case Rep. 2025 Mar 3;19(1):92. doi: 10.1186/s13256-025-05116-2.

Changing management in patients with papillary thyroid cancer.甲状腺乳头状癌患者的管理变化

Curr Treat Options Oncol. 2007 Aug;8(4):305-13. doi: 10.1007/s11864-007-0040-2.

Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.应用美国甲状腺协会的新指南导致甲状腺全切术的完成率大幅提高，以便进行辅助放射性碘治疗。

Surgery. 2017 Jan;161(1):127-133. doi: 10.1016/j.surg.2016.05.056. Epub 2016 Nov 14.

Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b).重组人促甲状腺素与甲状腺激素撤减在放射性碘辅助治疗甲状腺乳头状癌且临床明显淋巴结转移不限于中央区（cN1b）患者中的比较

Arch Endocrinol Metab. 2017 Mar-Apr;61(2):167-172. doi: 10.1590/2359-3997000000247. Epub 2017 Feb 13.

Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.首次放射性碘治疗后复发的甲状腺乳头状癌患者的临床结局

Cancer. 1996 Aug 1;78(3):493-501. doi: 10.1002/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-U.

Correlation analysis between the quantitative parameters of iodine-131 single-photon emission computed tomography-computed tomography thyroid bed uptake and the efficacy of radioactive iodine adjuvant therapy for papillary thyroid cancer.碘-131单光子发射计算机断层扫描-计算机断层扫描甲状腺床摄取定量参数与甲状腺乳头状癌放射性碘辅助治疗疗效的相关性分析

Quant Imaging Med Surg. 2024 May 1;14(5):3665-3675. doi: 10.21037/qims-23-1723. Epub 2024 Apr 26.

Papillary thyroid carcinoma in cervical lymph nodes with vanished thyroid gland after ablation of Graves' disease by radioactive iodine.放射性碘消融格雷夫斯病后甲状腺消失，颈部淋巴结出现甲状腺乳头状癌

Ann R Coll Surg Engl. 2019 May;101(5):e122-e124. doi: 10.1308/rcsann.2019.0033. Epub 2019 Mar 11.

本文引用的文献

Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.放射性碘治疗对中危甲状腺乳头状癌复发和生存结局的影响——系统评价和荟萃分析。

Clin Endocrinol (Oxf). 2024 Feb;100(2):181-191. doi: 10.1111/cen.15001. Epub 2023 Dec 4.

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.低危到中危甲状腺乳头状癌的放射性碘治疗。

Front Endocrinol (Lausanne). 2022 Aug 11;13:960682. doi: 10.3389/fendo.2022.960682. eCollection 2022.

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.侧颈部淋巴结比率是甲状腺乳头状癌伴淋巴结转移患者无复发生存的独立危险因素。

Endocrine. 2022 Dec;78(3):484-490. doi: 10.1007/s12020-022-03173-x. Epub 2022 Aug 26.

Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.术后未行放射性碘治疗分化型甲状腺癌时的血清甲状腺球蛋白测量：一项系统评价。

Thyroid. 2022 Jun;32(6):613-639. doi: 10.1089/thy.2021.0666. Epub 2022 May 10.

How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.需要切除多少个淋巴结？淋巴结比值小于 1/3 可降低甲状腺乳头状癌的淋巴结复发率。

Laryngoscope. 2022 Sep;132(9):1883-1887. doi: 10.1002/lary.30084. Epub 2022 Mar 1.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组

Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.

Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.辅助放射性碘治疗与中危乳头状甲状腺癌患者的生存率提高相关。

J Clin Endocrinol Metab. 2015 Apr;100(4):1529-36. doi: 10.1210/jc.2014-4332. Epub 2015 Feb 2.

Lymph node ratio predicts recurrence in papillary thyroid cancer.淋巴结比率可预测甲状腺乳头状癌的复发。

Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验